John H. Lunde YOU? Author Swipe

Last 10y

Combined Pathology-Driven Algorithmic Testing and Integrated Reporting for Bone Marrow Examination Open

L. Pearson, Jill M. Miller, John H. Lunde, Ronald J. Bryant, Michael R. Lewis , et al. · 2019

Context.— The College of American Pathologists published guideline recommending bone marrow synoptic reporting for hematologic neoplasms. Objective.— To evaluate the impact of pathology-driven algorithmic testing (PDAT) with integrated rep…

RARE-55. LANGERHAN’S CELL HISTIOCYTOSIS (LCH) ASSOCIATED WITH LEPTOMENINGEAL ACUTE MYELOID LEUKEMIA (AML): A CASE REPORT Open

Christopher Trevino, Alissa A. Thomas, Marie Wood, Gary P. Landrigan, John H. Lunde , et al. · 2016

LCH is a rare hematopoietic malignancy due to dendritic cell clonal proliferation, which commonly presents as sinusitis. Between 6 and 25% of LCH cases involve the central nervous system (CNS). LCH is rarely associated with other hematolog…